Evidence map›Paper›PMID 35970770›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2022

Fast Cysteine Bioconjugation Chemistry.

Fa-Jie Chen, Jianmin Gao

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. RSC medicinal chemistry · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Site-Selective Peptide and Protein Functionalization with Cyclopropenium Cations.Angewandte Chemie (International ed. in English) · 2025
    Article
  13. Advances in Proximity-Assisted Bioconjugation.Accounts of chemical research · 2025
    Review
  14. Article
  15. Article
  16. Direct Editing of Cysteine to Electrophilic Alkyl Halides in Peptides.Journal of the American Chemical Society · 2025
    Article
  17. Article
  18. Article
  19. Orthogonal Site-Specific Dual Bioconjugation of Aryl and Alkyl Thiols.Journal of the American Chemical Society · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fa-Jie ChenDepartment of Chemistry, Boston College, Merkert Chemistry Center, 2609 Beacon Street, Chestnut Hill, MA 02467, USA.
Jianmin GaoDepartment of Chemistry, Boston College, Merkert Chemistry Center, 2609 Beacon Street, Chestnut Hill, MA 02467, USA.ORCID http://orcid.org/0000-0001-9341-1287

Funding

Targeted Modification of Membrane LipidsR01GM102735 · NIGMS · BOSTON COLLEGE · PI GAO, JIANMIN · 2012 to 2021
$2.5M
Novel Phage Display Platforms to Overcome Colistin ResistanceR01GM124231 · NIGMS · BOSTON COLLEGE · PI GAO, JIANMIN · 2019 to 2022
$1.2M
National Science Foundation CHE-1904874National Science Foundation CHE-2117246NIGMS NIH HHS GM102735NIGMS NIH HHS GM124231NIGMS NIH HHS R01 GM102735NIGMS NIH HHS R01 GM124231
6 · The paper itself

Abstract

Cysteine bioconjugation serves as a powerful tool in biological research and has been widely used for chemical modification of proteins, constructing antibody-drug conjugates, and enabling cell imaging studies. Cysteine conjugation reactions with fast kinetics and exquisite selectivity have been under heavy pursuit as they would allow clean protein modification with just stoichiometric amounts of reagents, which minimizes side reactions, simplifies purification and broadens functional group tolerance. In this concept, we summarize the recent advances in fast cysteine bioconjugation, and discuss the mechanism and chemical principles that underlie the high efficiencies of the newly developed cysteine reactive reagents.

Indexed as

CysteineImmunoconjugatesIndicators and ReagentsProteinsCysteineImmunoconjugatesIndicators and ReagentsProteinscysteine bioconjugationfast kineticsN-terminal cysteineprotein modificationreaction rate constant

Identifiers

PMID35970770
PMCPMC9701160

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.